Sapporo Clinical Laboratory Inc.

TSE:9776 Stock Report

Market Cap: JP¥3.0b

Sapporo Clinical Laboratory Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Sapporo Clinical Laboratory.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Consumer Retailing earnings growth13.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Be Wary Of Sapporo Clinical Laboratory (TSE:9776) And Its Returns On Capital

Aug 06
Be Wary Of Sapporo Clinical Laboratory (TSE:9776) And Its Returns On Capital

Sapporo Clinical Laboratory's (TSE:9776) Weak Earnings May Only Reveal A Part Of The Whole Picture

May 21
Sapporo Clinical Laboratory's (TSE:9776) Weak Earnings May Only Reveal A Part Of The Whole Picture

Sapporo Clinical Laboratory (TYO:9776) Is Reinvesting At Lower Rates Of Return

Mar 29
Sapporo Clinical Laboratory (TYO:9776) Is Reinvesting At Lower Rates Of Return

Sapporo Clinical Laboratory (TYO:9776) Shareholders Have Enjoyed A 47% Share Price Gain

Feb 11
Sapporo Clinical Laboratory (TYO:9776) Shareholders Have Enjoyed A 47% Share Price Gain

Should You Use Sapporo Clinical Laboratory's (TYO:9776) Statutory Earnings To Analyse It?

Dec 24
Should You Use Sapporo Clinical Laboratory's (TYO:9776) Statutory Earnings To Analyse It?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sapporo Clinical Laboratory has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TSE:9776 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202419,816376-158674N/A
6/30/202419,759431N/AN/AN/A
3/31/202419,6823806301,077N/A
12/31/202319,729386N/AN/AN/A
9/30/202320,0255366141,566N/A
6/30/202320,149495N/AN/AN/A
3/31/202320,1275686051,430N/A
12/31/202220,074874N/AN/AN/A
9/30/202219,5078437681,233N/A
6/30/202219,3711,013N/AN/AN/A
3/31/202219,1091,0426261,573N/A
12/31/202118,802971N/AN/AN/A
9/30/202118,7041,025-1,5551,704N/A
6/30/202118,066901N/AN/AN/A
3/31/202117,502793-2,315837N/A
12/31/202017,299516N/AN/AN/A
9/30/202017,185427-49691N/A
6/30/202017,307348N/AN/AN/A
3/31/202017,659528-1,7281,255N/A
12/31/201917,532640N/AN/AN/A
9/30/201917,470643-1,826964N/A
6/30/201917,214637N/AN/AN/A
3/31/201917,065523399646N/A
12/31/201817,158548N/AN/AN/A
9/30/201817,176545556884N/A
6/30/201817,357558N/AN/AN/A
3/31/201817,459685N/A1,310N/A
12/31/201717,399655N/AN/AN/A
9/30/201717,338620N/A1,136N/A
6/30/201717,196625N/AN/AN/A
3/31/201717,055513N/A669N/A
12/31/201617,238509N/AN/AN/A
9/30/201617,366509N/A650N/A
6/30/201617,463499N/AN/AN/A
3/31/201617,528590N/A941N/A
12/31/201517,640659N/AN/AN/A
9/30/201517,462658N/A1,081N/A
6/30/201517,343691N/AN/AN/A
3/31/201517,166573N/A609N/A
12/31/201416,728424N/AN/AN/A
9/30/201416,682457N/A572N/A
6/30/201416,585400N/AN/AN/A
3/31/201416,549493N/A914N/A
12/31/201316,563622N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 9776's forecast earnings growth is above the savings rate (0.3%).

Earnings vs Market: Insufficient data to determine if 9776's earnings are forecast to grow faster than the JP market

High Growth Earnings: Insufficient data to determine if 9776's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 9776's revenue is forecast to grow faster than the JP market.

High Growth Revenue: Insufficient data to determine if 9776's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 9776's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y